Amneal Pharmaceuticals, Inc. - Class A (AMRX) by event type
AMRX moves most on coverage initiations — a median of +0.25% at 30 minutes across 15 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the AMRX overview →
How AMRX reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 985 of 2,717 | 19 | +0.12% | 53% | -1.99% |
| Coverage initiations 662 of 2,283 | 15 | +0.25% | 67% | +0.23% |
| Rating reiterations 1,583 of 3,522 | 25 | 0.00% | 48% | -0.12% |
| Price-target raises 454 of 1,790 | 12 | +0.09% | 50% | -0.24% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 1 further class was observed with fewer than 10 measured events and is not published.
That’s how AMRX usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · AMRX overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| REPRO MED SYSTEMS INC (REPR) | 378 | 0.00% | 26% |
| Akebia Therapeutics, Inc. (AKBA) | 377 | 0.00% | 49% |
| Autolus Therapeutics plc - American Depositary Shares (AUTL) | 377 | -0.00% | 45% |
| Solid Biosciences Inc. (SLDB) | 375 | -0.17% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.